TWI
TAK icon

Thomas White International’s Takeda Pharmaceutical TAK Stock Holding History

Thomas White International’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-84,485
Closed -$1.67M – 292
2019
Q4 		$1.67M Sell
84,485
-3,298
-4% -$63.1K 0.28% 113
2019
Q3 		$1.51M Sell
87,783
-1,842
-2% -$31.9K 0.28% 119
2019
Q2 		$1.59M Sell
89,625
-9,445
-10% -$172K 0.28% 103
2019
Q1 		$2.02M Buy
+99,070
New +$1.99M 0.36% 87

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Thomas White International's TAK Position: Q1 2020 in Review

Thomas White International sold out of Takeda Pharmaceutical (TAK) in Q1 2020, closing a stake of 84,485 shares — an estimated $1.67M sold.

Thomas White International first reported a position in TAK in Q1 2019 and held it in 4 quarters. The position peaked at $2.02M in Q1 2019. 312 funds tracked by Wall St. Rank hold TAK as of Q1 2020.

  • Thomas White International reported no remaining Takeda Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Thomas White International sold 84,485 Takeda Pharmaceutical shares in Q1 2020, an estimated $1.67M.
  • Thomas White International first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 4 quarters.
  • Thomas White International's Takeda Pharmaceutical position peaked at $2.02M in Q1 2019.
  • 312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2020.

Based on Thomas White International's 13F filing for Q1 2020, filed 12 May 2020.